Mersana Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Mersana Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mersana Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Mersana Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $13M | 2.9M | 4.48 |
| 2023-09-30 | $1.3M | 986k | 1.27 |
| 2023-06-30 | $2.7M | 765k | 3.50 |
| 2022-12-31 | $10M | 1.8M | 5.86 |
| 2022-06-30 | $6.4M | 1.6M | 4.05 |
| 2022-03-31 | $8.6M | 2.2M | 3.94 |
| 2021-06-30 | $1.7M | 126k | 13.55 |
| 2020-12-31 | $1.2M | 46k | 26.61 |
| 2020-09-30 | $265k | 14k | 18.56 |
| 2020-06-30 | $498k | 21k | 23.42 |
| 2020-03-31 | $28k | 4.9k | 5.76 |
| 2019-12-31 | $435k | 76k | 5.72 |
| 2019-09-30 | $27k | 18k | 1.54 |
| 2019-03-31 | $36k | 6.8k | 5.27 |
| 2018-12-31 | $79k | 19k | 4.07 |
| 2018-09-30 | $206k | 21k | 10.00 |
| 2018-06-30 | $476k | 27k | 17.85 |
| 2018-03-31 | $387k | 25k | 15.77 |
| 2017-12-31 | $237k | 14k | 16.45 |